该公司主要从事骨科和脊柱生物学领域。它提供固定系统和生物学产品,旨在治疗脊柱和骨科疾病。
排他性优势:
1. 拥有强大的研发能力,能不断开发和推出创新产品,如新的固定系统和生物学产品。
2. 构建了一个互补的产品组合,包括固定和生物学解决方案,能...查看全文
$Xtant医控股(XTNT)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001493152-23-000906 Act: 34 Size: 536 KB 网页链接
$Xtant医控股(XTNT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001235802-22-000122 Size: 5 KB 网页链接
$Xtant医控股(XTNT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-22-030284 Act: 34 Size: 4 MB 网页链接
$Xtant医控股(XTNT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-22-030277 Act: 34 Size: 570 KB 网页链接
$Xtant医控股(XTNT)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001493152-22-029853 Act: 33 Size: 108 KB 网页链接
$Xtant医控股(XTNT)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001493152-22-029849 Act: 34 Size: 514 KB 网页链接
$Xtant医控股(XTNT)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-22-003097 Act: 33 Size: 1 KB 网页链接
$Xtant医控股(XTNT)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001493152-22-029243 Act: 33 Size: 278 KB 网页链接
$Xtant医控股(XTNT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001235802-22-000114 Size: 8 KB 网页链接
$Xtant医控股(XTNT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001235802-22-000113 Size: 8 KB 网页链接